The Experts below are selected from a list of 369 Experts worldwide ranked by ideXlab platform
Milena Kresovic - One of the best experts on this subject based on the ideXlab platform.
-
Is oxytocin given during surgical termination of first trimester pregnancy useful? A randomized controlled trial.
Acta Obstetricia et Gynecologica Scandinavica, 2010Co-Authors: Ingerid Helene Herstad Nygaard, Annelill Valbø, Helene Christine Heide, Milena KresovicAbstract:Objective. To compare the impact of 5 IU (international units) of oxytocin administered during surgical termination of first-trimester pregnancy compared to no oxytocin, on postoperative bleeding, pain and nausea. Design. A randomized controlled single-blinded study. Setting. A Norwegian community hospital with 1,064 consecutive legal abortions in the 20 months of study period. Sample. A total of 378 women undergoing surgical termination of first-trimester pregnancy and willing to participate in the study Methods. Women were randomized into two groups: Group 1, receiving a standard procedure of 5 IU of oxytocin during the surgical procedure, or Group 2, receiving no Oxytocic Agent. All women had preoperative misoprostol. Main Outcome Measures. Vaginal bleeding, pain and nausea recorded by weighing pads immediately after the surgical procedure and counting pads during the three following days. Results. No significant differences between the two groups could be demonstrated with regard to the recorded postoperative blood loss, pain and nausea. Conclusions. The standard routine of administering oxytocin during surgical termination of first-trimester pregnancy should be revised.
Ingerid Helene Herstad Nygaard - One of the best experts on this subject based on the ideXlab platform.
-
Is oxytocin given during surgical termination of first trimester pregnancy useful? A randomized controlled trial.
Acta Obstetricia et Gynecologica Scandinavica, 2010Co-Authors: Ingerid Helene Herstad Nygaard, Annelill Valbø, Helene Christine Heide, Milena KresovicAbstract:Objective. To compare the impact of 5 IU (international units) of oxytocin administered during surgical termination of first-trimester pregnancy compared to no oxytocin, on postoperative bleeding, pain and nausea. Design. A randomized controlled single-blinded study. Setting. A Norwegian community hospital with 1,064 consecutive legal abortions in the 20 months of study period. Sample. A total of 378 women undergoing surgical termination of first-trimester pregnancy and willing to participate in the study Methods. Women were randomized into two groups: Group 1, receiving a standard procedure of 5 IU of oxytocin during the surgical procedure, or Group 2, receiving no Oxytocic Agent. All women had preoperative misoprostol. Main Outcome Measures. Vaginal bleeding, pain and nausea recorded by weighing pads immediately after the surgical procedure and counting pads during the three following days. Results. No significant differences between the two groups could be demonstrated with regard to the recorded postoperative blood loss, pain and nausea. Conclusions. The standard routine of administering oxytocin during surgical termination of first-trimester pregnancy should be revised.
Charles Bahary - One of the best experts on this subject based on the ideXlab platform.
-
Uterine rupture at term pregnancy with the use of intracervical prostaglandin E2, gel for induction of labor
American journal of obstetrics and gynecology, 1991Co-Authors: Ron Maymon, Adrian Shulman, Meir Pomeranz, Michael Holtzinger, Luis Haimovich, Charles BaharyAbstract:Prostaglandin E 2 is a powerful Oxytocic Agent that reliably initiates labor, even in the presence of an unripe cervix. The low incidence of fetomaternal complication contributes to its universal use. We report a rare case of uterine rupture after intracervical application of prostaglandin E 2 gel. Thus far no prostaglandin compound or method of administration seems to be exempt from such a complication.
Helene Christine Heide - One of the best experts on this subject based on the ideXlab platform.
-
Is oxytocin given during surgical termination of first trimester pregnancy useful? A randomized controlled trial.
Acta Obstetricia et Gynecologica Scandinavica, 2010Co-Authors: Ingerid Helene Herstad Nygaard, Annelill Valbø, Helene Christine Heide, Milena KresovicAbstract:Objective. To compare the impact of 5 IU (international units) of oxytocin administered during surgical termination of first-trimester pregnancy compared to no oxytocin, on postoperative bleeding, pain and nausea. Design. A randomized controlled single-blinded study. Setting. A Norwegian community hospital with 1,064 consecutive legal abortions in the 20 months of study period. Sample. A total of 378 women undergoing surgical termination of first-trimester pregnancy and willing to participate in the study Methods. Women were randomized into two groups: Group 1, receiving a standard procedure of 5 IU of oxytocin during the surgical procedure, or Group 2, receiving no Oxytocic Agent. All women had preoperative misoprostol. Main Outcome Measures. Vaginal bleeding, pain and nausea recorded by weighing pads immediately after the surgical procedure and counting pads during the three following days. Results. No significant differences between the two groups could be demonstrated with regard to the recorded postoperative blood loss, pain and nausea. Conclusions. The standard routine of administering oxytocin during surgical termination of first-trimester pregnancy should be revised.
Annelill Valbø - One of the best experts on this subject based on the ideXlab platform.
-
Is oxytocin given during surgical termination of first trimester pregnancy useful? A randomized controlled trial.
Acta Obstetricia et Gynecologica Scandinavica, 2010Co-Authors: Ingerid Helene Herstad Nygaard, Annelill Valbø, Helene Christine Heide, Milena KresovicAbstract:Objective. To compare the impact of 5 IU (international units) of oxytocin administered during surgical termination of first-trimester pregnancy compared to no oxytocin, on postoperative bleeding, pain and nausea. Design. A randomized controlled single-blinded study. Setting. A Norwegian community hospital with 1,064 consecutive legal abortions in the 20 months of study period. Sample. A total of 378 women undergoing surgical termination of first-trimester pregnancy and willing to participate in the study Methods. Women were randomized into two groups: Group 1, receiving a standard procedure of 5 IU of oxytocin during the surgical procedure, or Group 2, receiving no Oxytocic Agent. All women had preoperative misoprostol. Main Outcome Measures. Vaginal bleeding, pain and nausea recorded by weighing pads immediately after the surgical procedure and counting pads during the three following days. Results. No significant differences between the two groups could be demonstrated with regard to the recorded postoperative blood loss, pain and nausea. Conclusions. The standard routine of administering oxytocin during surgical termination of first-trimester pregnancy should be revised.
